Insider · CIK 0001471971
Elizabeth Cermak
Files at MBRX (Moleculin Biotech, Inc.). First filing -, latest -.
Elizabeth Cermak files SEC Form 4 as director at MBRX (Moleculin Biotech, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Elizabeth Cermak has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | MBRX Moleculin Biotech, Inc. | AGrant or award Stock Options (right to buy)derivative | +150,000 | - | - | 164,668 | Nov 14, 2025 |
| Nov 4, 2024 | MBRX Moleculin Biotech, Inc. | AGrant or award Stock option (right to buy)derivative | +10,000 | - | - | 14,668 | Nov 6, 2024 |
Questions about Elizabeth Cermak
Answered from the filings on this page, as of the latest one.
Is Elizabeth Cermak buying or selling?
Elizabeth Cermak has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Elizabeth Cermak's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Elizabeth Cermak has 0.
Where does Elizabeth Cermak file Form 4?
Elizabeth Cermak has filed Form 4 at MBRX (Moleculin Biotech, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.